If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]
Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]
We are now in the second term of President Obama’s term in office. While the Presidential Cycle Pattern shows similarities among all presidential terms in the stock market’s behavior, it is poorly appreciated how the 2nd term is often different from the first in its character.The lead chart this week compares the current behavior of the SP500 to an average […]
Short term momentum extremes over a month period tend to mean revert. A recent example of this is CUBA which went parabolic with gains in excess of 100% over a 4 day period. Another example from last September/October is LAKE which gained nearly 400% over month.
CUBA
LAKE
One approach to these types of extreme moves is to devise tactics for shorting, particularly […]
It’s been an eventful and promising year for pharma. The eyeforpharma team choose their top five pharma news stories of 2014.Globally, healthcare is high on citizens’ and policy-makers’ agendas and, wherever healthcare and business intersect, we find controversy. Indeed, this year, pharma has hardly seemed to be out of the headlines, becoming part of the international news agenda on several […]
Biodefense Breaking News: Aethlon Medical (OTCBB: AEMD) Announces First Hemopurifier® Shipment To Support the Treatment of Ebola in the United StatesSAN DIEGO – November 26, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today announced the first shipment of Hemopurifier® therapy as a candidate to treat future Ebola […]
Morningstar.comJeremy GranthamYou could argue that Jeremy Grantham is bullish.In a new quarterly letter to GMO clients, the gloomy veteran fund manager predicts the S&P 500 could see another 10% surge from the 2,041 level we’re at today.”My personal fond hope and expectation is still for a market that runs deep into bubble territory (which starts… at 2250 on the S&P […]
Editor’s note: Nuria Oliver is a scientific director at Telefonica looking at how the use of big data can help to fight pandemics such as Ebola and bird flu.Last year, I gave a talk at WIRED 2013 on how anonymous and aggregated mobile phone data can be used to understand and combat the spread of infectious diseases. I described a study that we […]
That bright neon sign you’re looking at are biotech stocks flashing, “Buy me!”So put down your morning joe. Go ahead, do it. And ignore all incoming e-mail for the next few minutes. Because the biotech breakout has arrived — and it can make you a bundle over the next few months.That’s right. Forget about this month’s stock roller-coaster ride. Yeah, sure, it […]
(Spencer Platt/Getty Images)
What a difference a week makes. In the throes of the worst of Wall Street’s turbulence, news of an Ebola diagnosis in New York City might have been enough to send stocks right off the rails and shares of biotech and biohazard protection stocks soaring.That wasn’t the case Friday though, as the market took news of a […]
